Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Susan Young Rojahn

A View from Susan Young Rojahn

More Near-Cures for HIV

Early treatment may be key to a drug-free life for a small percentage of patients.

  • March 15, 2013

Last week, scientists reported that a baby had been “functionally cured” of HIV (see “A Toddler May Have Been Cured of HIV Infection”). Now, other researchers report in PLoS Pathogens that 14 HIV-infected adults—four women and 10 men—have survived with the virus in check even though they have stopped taking their antiretroviral medications.  

The authors write that while combined antiretroviral drugs reduce HIV-associated illness and death, they cannot cure the infection. The 14 patients in the study are functionally cured, meaning they are not completely rid of the virus—although they have no symptoms, very low levels of HIV can still be detected in their blood.  “Given the difficulty of eradicating [HIV], a functional cure for HIV-infected patients appears to be a more reachable short-term goal,” they write.

But bear in mind that the 14 adults who were functionally cured were part of a larger study of 70 people who had gone off of their antiretroviral drugs. The majority of the group relapsed when their treatment stopped. The key now is to find out what makes the 14 adults different. They did not carry known protective genetic variants and actually had more severe infections and more symptoms before starting treatment. This sensitivity may have helped by prompting the patients to seek treatment sooner than most people, write the researchers who conclude that:

“These findings argue in favor of early [combined antiretroviral therapy] initiation and open up new therapeutic perspectives for HIV-1-infected patients.”

Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.

Subscribe today

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.